PRESS RELEASE For immediate release Devonian Announces Closing of a Private Placement of $500,000 Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, September 1, 2023 – Devonian Health Group Inc. (“Devonian” or...
Press Releases
Devonian Health Group receives a Notice of Allowance for Issuance of a U.S. Patent on a method of treatment of Inflammatory Bowel Disease.
PRESS RELEASE For immediate release Devonian Health Group receives a Notice of Allowance for Issuance of a U.S. Patent on a method of treatment of Inflammatory Bowel Disease. QUEBEC, – June 20, 2023 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV:...
Devonian Announces Closing of a Private Placement of $1.2 Million
PRESS RELEASE For immediate release Devonian Announces Closing of a Private Placement of $1.2 Million Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, June 6, 2023 – Devonian Health Group Inc. (“Devonian” or the...
Devonian Announces Private Placement of up to $5 Million
PRESS RELEASE For immediate release Devonian Announces Private Placement of up to $5 Million. Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, May 19, 2023 – Devonian Health Group Inc. (“Devonian” or the...
Devonian Health Group announces presentation of Thykamine™ efficacy results in Atopic Dermatitis at the World Congress of Dermatology and provides Thykamine™ Clinical Development Program Update.
PRESS RELEASE For immediate release Devonian Health Group announces presentation of Thykamine™ efficacy results in Atopic Dermatitis at the World Congress of Dermatology and provides Thykamine™ Clinical Development Program Update. QUEBEC, – May 16, 2023 – Devonian...
DEVONIAN HEALTH GROUP ANNOUNCES THE APPOINTMENT OF NEW BOARD MEMBERS AND GRANT OF STOCK OPTIONS.
PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP ANNOUNCES THE APPOINTMENT OF NEW BOARD MEMBERS AND GRANT OF STOCK OPTIONS. QUEBEC, – May 12, 2023 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB : DVHGF), a clinical late stage...
Devonian Announces Filing of Preliminary Base Shelf Prospectus
PRESS RELEASE For immediate release Devonian Announces Filing of Preliminary Base Shelf Prospectus QUEBEC, May 11, 2023 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation,...
Devonian Announces Approval of Amendments to its Stock Option Plan and its Restricted Share Unit Plan
PRESS RELEASE For immediate release Devonian Announces Approval of Amendments to its Stock Option Plan and its Restricted Share Unit Plan Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, March 30th, 2023 –...
Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members.
PRESS RELEASE For immediate release Devonian Health Group Announces Hybrid Shareholders’ Annual General and Special Meeting QUEBEC, – March 24th, 2023 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB : DVHGF), a clinical stage botanical...
Devonian Health Group Announces Hybrid Shareholders’ Annual General and Special Meeting
PRESS RELEASE For immediate release Devonian Health Group Announces Hybrid Shareholders’ Annual General and Special Meeting QUEBEC, February 22nd, 2023 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage botanical...